RECENT NEWS
£400 million investment to boost UK clinical trials
NHS patients will have earlier access to new treatments and the UK will become the home of cutting-edge health research as the UK government launches a joint public-private investment programme worth up to £400 million.
Indica Labs and Paige forge new partnership
Indica Labs, a provider of computational pathology software, and AI technology firm Paige have formed a non-exclusive partnership aimed at integrating Paige’s diagnostic AI models into Indica’s anatomic pathology workflow management software, HALO AP.
SYNLAB wins pathology contract for Mid and South Essex
SYNLAB, has been chosen as the preferred supplier for the delivery of a single, outsourced pathology service to the Mid and South Essex NHS Foundation Trust. Used by all GPs in the region as well as Southend, Basildon and Broomfield hospitals, this service will include blood, tissue and other sample testing as well as the operation of phlebotomy clinics.
QuantaMatrix unveils ‘fastest’ antimicrobial testing technology
Clinical microbiology diagnostics firm QuantaMatrix has announced the development of 'uRAST' (Ultra-Rapid Antimicrobial Susceptibility Testing), the world’s fastest all-in-one antimicrobial testing technology.
StatLab to acquire Italian equipment maker Diapath
StatLab Medical Products has announced that it has reached an agreement to acquire Diapath, an Italian manufacturer of histology and cytology products and equipment.
NIH grant to establishes new TB research centre
A $5.8 million grant led by Adrie Steyn PhD, of the University of Alabama at Birmingham and the Africa Health Research Institute (AHRI) in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.
WHO launches response plan for mpox outbreak
The World Health Organization (WHO) has launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts. This follows the declaration of a public health emergency of international concern by the WHO Director-General.
Advances in DNA vaccine targeting Zika virus
Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a new collaboration with specialist company Touchlight, which will provide new technology to produce large quantities of the DNA vaccine at speed.
Drones used ‘beyond line of sight’ for NHS first
Blood packs have been successfully flown by drone in a series of ‘beyond visual line of sight’ flights, for the first time in the UK. This is the first in a series of NHS trials as part of a study to ascertain the feasibility and safety of delivering medical supplies via drone.
PreciseDx secures funding to advance AI-powered breast cancer risk assessments
PreciseDx, a leading innovator in oncology diagnostics leveraging artificial intelligence (AI) for new, morphology-driven disease analysis, has announced that it has raised $20.7 million in Series B funding, bringing its total funding to date to $31.5 million.
Introducing Amplify Rigid PCR plates
Alpha Laboratories has launched its new Amplify Rigid PCR plates, designed to set a new standard in laboratory efficiency and reliability. These innovative plates feature a rugged polycarbonate frame, providing a solid and flat surface that ensures seamless interaction with automated liquid handling platforms.
Roche working to enhance mpox testing
Roche has said that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox, formerly known as monkeypox.
Paige introduces OmniScreen AI tool
Digital pathology and AI firm Paige has announed the launch of OmniScreen, a pioneering AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 molecular biomarkers from routine H&E-stained digital pathology slides.
Register now for Lab Innovations 2024
Visitor registration for Lab Innovations 2024 is now live. The UK’s largest annual exhibition for the whole laboratory industry will take place at the NEC, Birmingham, on 30-31 October, featuring engaging talks and exhibitors that will showcase innovation and champion sustainability.
Synnovis restores testing services
Pathology services provider Synnovis has recently confirmed it has rebuilt its core IT systems following the cyberattack on 3 June. It has now resumed testing services for GPs in Bexley, Lewisham and Greenwich, three of the six boroughs it serves.
New study shows difficulty of diagnosing Long COVID
A new study has found that most routine laboratory tests are not reliable for diagnosing Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
WHO declares mpox outbreak a public health emergency
WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations.
RCPath submits evidence to NHS review
The Royal College of Pathologists (RCPath) has submitted evidence to Lord Darzi's review of the NHS outlining the challenges and opportunities facing pathology services.
Strategic partnership to revolutionise urine testing
Alpha Laboratories has entered into a strategic partnership with Clinical Design Technologies to market and support that company's digital closed urine testing system. This innovative technology offers unmatched clinical efficacy, simplicity, and accuracy, setting a new standard for urinalysis at the point of care.
Roche finalises acquisition of LumiraDx’s POC technology
Roche has recently announced the completion of the acquisition of LumiraDx’s point-of-care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company’s innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organisation.
Latest Issues
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
Medica
Messe Dusseldorf
11-14 November, 2024
POCT-for-Scot: Bringing the future to you
SEC Arena, Glasgow
14 November, 2024
Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo
Hyatt Regency, Vancouver, Canada
19-23 November, 2024
Advances in Transfusion Medicine 2024 – Joint RCPath & SHOT Symposium
Online
20-21 November, 2024
11th Digital Pathology & AI Congress: Europe
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024